Compare Twenty-four seven, Inc. with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -18.75% and Operating profit at 14.72% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -429.89
Negative results in May 25
Risky - Negative EBITDA
Below par performance in long term as well as near term
Stock DNA
Computers - Software & Consulting
JPY 1,943 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-5.15
-217.29%
21.74
Total Returns (Price + Dividend) 
Twenty-four seven, Inc. for the last several years.
Risk Adjusted Returns v/s 
News

Twenty-four Seven, Inc. Faces Financial Challenges Amid Stock Rating Downgrade
Twenty-four Seven, Inc. has experienced a significant evaluation adjustment, moving from 'Not Rated' to 'Strong Sell' according to MarketsMOJO. This change reflects a decline in financial metrics, including a negative return on equity and declining net sales, raising concerns about the company's long-term growth prospects.
Read full news article Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot
Shareholding Compare (%holding) 
Quarterly Results Snapshot (Consolidated) - Nov'25 - QoQ
QoQ Growth in quarter ended Nov 2025 is 1.05% vs 15.06% in Aug 2025
QoQ Growth in quarter ended Nov 2025 is 55.14% vs 7.24% in Aug 2025
Annual Results Snapshot (Consolidated) - Nov'25
YoY Growth in year ended Nov 2025 is -17.12% vs -21.34% in Nov 2024
YoY Growth in year ended Nov 2025 is 51.85% vs 9.34% in Nov 2024






